Updated:
Doximity
Doximity is the dominant mobile network for US physicians, connecting over 80% of doctors for clinical communication and telehealth.
Doximity
Doximity launched in 2010, founded by Jeff Tangney and Nate Gross with the premise that healthcare professionals needed a secure, closed-loop communication network separate from consumer social platforms. Tangney, who previously co-founded mobile medical reference app Epocrates, replicated the model of building a massive professional user base and monetizing through precision communications — essentially creating a LinkedIn for medicine that prioritizes HIPAA-compliant messaging and clinical workflows. The firm operates a multi-tenant platform serving physicians, nurse practitioners, and other clinicians through tools like a professional dialer that masks personal phone numbers, a curated medical news feed, and telehealth capabilities. Doximity generates revenue by selling subscription-based hiring and marketing solutions to pharmaceutical companies and health systems that want to reach verified prescribers. Its product suite covers telehealth (Doximity Video), physician scheduling, and an AI-powered medical writing assistant, forming an ecosystem designed to increase clinician time on platform. Strategic acquisitions, including Amion for physician scheduling and a previously undisclosed telehealth asset, have expanded its operational footprint. Doximity went public on the New York Stock Exchange in June 2021 under the ticker DOCS, disclosing at the time that its cloud-based platform served over 1.8 million US medical professionals. The firm operated profitably before and after its listing — a rarity among venture-backed digital health companies. As of its fiscal 2024 filings, the firm had repurchased over $200 million in shares, signaling a capital allocation philosophy that favors returning cash to holders over pursuing unprofitable growth. Doximity's structural differentiator is its network density within a regulated industry with high barriers to consumer social media adoption: over 80% of US physicians have verified profiles, creating a near-monopoly on closed-loop clinical communication. This physician concentration gives the firm pricing power against pharma advertisers who struggle to reach prescribers through other compliant channels. The dual-class stock structure preserves insider voting control despite its public listing, insulating the long-term product roadmap from quarterly activism — a governance model that locks founder Tangney as the decisive strategic voice.
General information
Firm type
Asset Manager
Year founded
2010
AUM
Undisclosed
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
San Francisco, CA, United States
Principals
Jeff Tangney
Chief Executive Officer
Nate Gross
Chief Strategy Officer
Sector focus
Frequently asked questions
Who runs product and strategic direction at Doximity?
Co-founder and CEO Jeff Tangney leads the company's strategic vision. He previously co-founded Epocrates, a mobile drug-reference app that went public in 2011 before being acquired by Athenahealth. Co-founder Nate Gross, a physician, serves as Chief Strategy Officer and shapes the product's clinical utility.
How does Doximity generate revenue without charging physicians?
Doximity monetizes physician attention and verified credentials by charging pharmaceutical companies and health systems for precision marketing and hiring tools. The platform's verified prescriber data allows advertisers to reach specific specialties and regions in a compliant manner. The core product remains free for clinicians to maintain network density.
What distinguishes Doximity's physician network from competitors like LinkedIn or Doximity clones?
Doximity verifies medical credentials against state and national databases before granting full access, creating a closed loop absent on consumer platforms. Its tools — a HIPAA-compliant dialer that masks personal numbers, clinical news curated by peers, and integrated telehealth — are workflow utilities rather than social features. Attempted competitors including Figure 1 and Sermo have not replicated its combination of credential verification and clinical workflow integration.
Does Doximity operate as a growth-stage startup or a mature public company?
Doximity has operated as a public company since its June 2021 NYSE listing. Unlike many growth-stage digital health companies, it has generated consistent GAAP profitability. The firm's capital allocation includes share repurchases exceeding $200 million, which positions it closer to a mature enterprise software company than a cash-burning growth equity asset.
How does Doximity's telehealth product fit into its broader business model?
Doximity Video is a free telehealth tool available to any verified physician on the network. It functions as a retention and engagement feature rather than a standalone revenue center. By providing compliant video visits without per-use charges, the firm deepens daily active use and increases platform stickiness, which indirectly supports its marketing and hiring revenue streams.
What regulatory risk does Doximity face as a conduit for pharma marketing?
Doximity operates at the intersection of digital advertising and healthcare compliance. The platform's reliance on pharma marketing budgets exposes it to shifts in regulatory guidance around physician-directed promotion. The company mitigates this by vetting all messaging for regulatory compliance and maintaining audit trails, but a broad reinterpretation of anti-kickback statutes or transparency reporting could alter advertiser demand.
Is Doximity a family office or does it manage outside capital?
Doximity is not a family office. It is a publicly listed enterprise software and digital health company. The firm does not manage or deploy private capital on behalf of families or institutions; its capital allocation is limited to its own corporate treasury management and shareholder returns.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: